Advisor Group Holdings, Inc. Acurx Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,175 shares of ACXP stock, worth $5,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,175
Previous 14,210
0.25%
Holding current value
$5,244
Previous $26,000
57.69%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.52MCall Options Held
13.6KPut Options Held
4K-
Vanguard Group Inc Valley Forge, PA529KShares$195,8590.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$135,6330.08% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$54,2050.0% of portfolio
-
Morgan Stanley New York, NY106KShares$39,2940.0% of portfolio
-
Vanguard Capital Wealth Advisors67.5KShares$24,9750.03% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $4.28M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...